PCSK9 Inhibitors Market
1 Study Coverage
1.1 PCSK9 Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global PCSK9 Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Epatha(Evolocumab)
1.2.3 Praluent(Alirocumab)
1.2.4 Bococizumab
1.2.5 Others
1.3 Market by Application
1.3.1 Global PCSK9 Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical Application
1.3.3 Drug Development
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global PCSK9 Inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global PCSK9 Inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global PCSK9 Inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global PCSK9 Inhibitors Sales by Region
2.4.1 Global PCSK9 Inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales PCSK9 Inhibitors by Region (2023-2028)
2.5 Global PCSK9 Inhibitors Revenue by Region
2.5.1 Global PCSK9 Inhibitors Revenue by Region (2017-2022)
2.5.2 Global PCSK9 Inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global PCSK9 Inhibitors Sales by Manufacturers
3.1.1 Global Top PCSK9 Inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global PCSK9 Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PCSK9 Inhibitors in 2021
3.2 Global PCSK9 Inhibitors Revenue by Manufacturers
3.2.1 Global PCSK9 Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global PCSK9 Inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by PCSK9 Inhibitors Revenue in 2021
3.3 Global PCSK9 Inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global PCSK9 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global PCSK9 Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global PCSK9 Inhibitors Sales by Type
4.1.1 Global PCSK9 Inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global PCSK9 Inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
4.2 Global PCSK9 Inhibitors Revenue by Type
4.2.1 Global PCSK9 Inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global PCSK9 Inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global PCSK9 Inhibitors Price by Type
4.3.1 Global PCSK9 Inhibitors Price by Type (2017-2022)
4.3.2 Global PCSK9 Inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global PCSK9 Inhibitors Sales by Application
5.1.1 Global PCSK9 Inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global PCSK9 Inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
5.2 Global PCSK9 Inhibitors Revenue by Application
5.2.1 Global PCSK9 Inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global PCSK9 Inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global PCSK9 Inhibitors Price by Application
5.3.1 Global PCSK9 Inhibitors Price by Application (2017-2022)
5.3.2 Global PCSK9 Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America PCSK9 Inhibitors Market Size by Type
6.1.1 North America PCSK9 Inhibitors Sales by Type (2017-2028)
6.1.2 North America PCSK9 Inhibitors Revenue by Type (2017-2028)
6.2 North America PCSK9 Inhibitors Market Size by Application
6.2.1 North America PCSK9 Inhibitors Sales by Application (2017-2028)
6.2.2 North America PCSK9 Inhibitors Revenue by Application (2017-2028)
6.3 North America PCSK9 Inhibitors Market Size by Country
6.3.1 North America PCSK9 Inhibitors Sales by Country (2017-2028)
6.3.2 North America PCSK9 Inhibitors Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe PCSK9 Inhibitors Market Size by Type
7.1.1 Europe PCSK9 Inhibitors Sales by Type (2017-2028)
7.1.2 Europe PCSK9 Inhibitors Revenue by Type (2017-2028)
7.2 Europe PCSK9 Inhibitors Market Size by Application
7.2.1 Europe PCSK9 Inhibitors Sales by Application (2017-2028)
7.2.2 Europe PCSK9 Inhibitors Revenue by Application (2017-2028)
7.3 Europe PCSK9 Inhibitors Market Size by Country
7.3.1 Europe PCSK9 Inhibitors Sales by Country (2017-2028)
7.3.2 Europe PCSK9 Inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific PCSK9 Inhibitors Market Size by Type
8.1.1 Asia Pacific PCSK9 Inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific PCSK9 Inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific PCSK9 Inhibitors Market Size by Application
8.2.1 Asia Pacific PCSK9 Inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific PCSK9 Inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific PCSK9 Inhibitors Market Size by Region
8.3.1 Asia Pacific PCSK9 Inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific PCSK9 Inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America PCSK9 Inhibitors Market Size by Type
9.1.1 Latin America PCSK9 Inhibitors Sales by Type (2017-2028)
9.1.2 Latin America PCSK9 Inhibitors Revenue by Type (2017-2028)
9.2 Latin America PCSK9 Inhibitors Market Size by Application
9.2.1 Latin America PCSK9 Inhibitors Sales by Application (2017-2028)
9.2.2 Latin America PCSK9 Inhibitors Revenue by Application (2017-2028)
9.3 Latin America PCSK9 Inhibitors Market Size by Country
9.3.1 Latin America PCSK9 Inhibitors Sales by Country (2017-2028)
9.3.2 Latin America PCSK9 Inhibitors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa PCSK9 Inhibitors Market Size by Type
10.1.1 Middle East and Africa PCSK9 Inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa PCSK9 Inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa PCSK9 Inhibitors Market Size by Application
10.2.1 Middle East and Africa PCSK9 Inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa PCSK9 Inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa PCSK9 Inhibitors Market Size by Country
10.3.1 Middle East and Africa PCSK9 Inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa PCSK9 Inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Overview
11.1.3 Amgen PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Overview
11.2.3 Eli Lilly PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Eli Lilly PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eli Lilly Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novartis PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Roche PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Alnylam
11.8.1 Alnylam Corporation Information
11.8.2 Alnylam Overview
11.8.3 Alnylam PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Alnylam PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Alnylam Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AstraZeneca PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Affiris
11.10.1 Affiris Corporation Information
11.10.2 Affiris Overview
11.10.3 Affiris PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Affiris PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Affiris Recent Developments
11.11 BMS
11.11.1 BMS Corporation Information
11.11.2 BMS Overview
11.11.3 BMS PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 BMS PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BMS Recent Developments
11.12 Ionis Pharmaceuticals
11.12.1 Ionis Pharmaceuticals Corporation Information
11.12.2 Ionis Pharmaceuticals Overview
11.12.3 Ionis Pharmaceuticals PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Ionis Pharmaceuticals PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Ionis Pharmaceuticals Recent Developments
11.13 Cyon Therapeutics
11.13.1 Cyon Therapeutics Corporation Information
11.13.2 Cyon Therapeutics Overview
11.13.3 Cyon Therapeutics PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Cyon Therapeutics PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Cyon Therapeutics Recent Developments
11.14 Daiichi Sankyo
11.14.1 Daiichi Sankyo Corporation Information
11.14.2 Daiichi Sankyo Overview
11.14.3 Daiichi Sankyo PCSK9 Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Daiichi Sankyo PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Daiichi Sankyo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 PCSK9 Inhibitors Industry Chain Analysis
12.2 PCSK9 Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PCSK9 Inhibitors Production Mode & Process
12.4 PCSK9 Inhibitors Sales and Marketing
12.4.1 PCSK9 Inhibitors Sales Channels
12.4.2 PCSK9 Inhibitors Distributors
12.5 PCSK9 Inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 PCSK9 Inhibitors Industry Trends
13.2 PCSK9 Inhibitors Market Drivers
13.3 PCSK9 Inhibitors Market Challenges
13.4 PCSK9 Inhibitors Market Restraints
14 Key Findings in The Global PCSK9 Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global PCSK9 Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Epatha(Evolocumab)
Table 3. Major Manufacturers of Praluent(Alirocumab)
Table 4. Major Manufacturers of Bococizumab
Table 5. Major Manufacturers of Others
Table 6. Global PCSK9 Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global PCSK9 Inhibitors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global PCSK9 Inhibitors Sales by Region (2017-2022) & (K Units)
Table 9. Global PCSK9 Inhibitors Sales Market Share by Region (2017-2022)
Table 10. Global PCSK9 Inhibitors Sales by Region (2023-2028) & (K Units)
Table 11. Global PCSK9 Inhibitors Sales Market Share by Region (2023-2028)
Table 12. Global PCSK9 Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global PCSK9 Inhibitors Revenue Market Share by Region (2017-2022)
Table 14. Global PCSK9 Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global PCSK9 Inhibitors Revenue Market Share by Region (2023-2028)
Table 16. Global PCSK9 Inhibitors Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global PCSK9 Inhibitors Sales Share by Manufacturers (2017-2022)
Table 18. Global PCSK9 Inhibitors Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global PCSK9 Inhibitors Revenue Share by Manufacturers (2017-2022)
Table 20. PCSK9 Inhibitors Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global PCSK9 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global PCSK9 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCSK9 Inhibitors as of 2021)
Table 23. PCSK9 Inhibitors Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers PCSK9 Inhibitors Product Offered
Table 25. Date of Manufacturers Enter into PCSK9 Inhibitors Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 28. Global PCSK9 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 29. Global PCSK9 Inhibitors Sales Share by Type (2017-2022)
Table 30. Global PCSK9 Inhibitors Sales Share by Type (2023-2028)
Table 31. Global PCSK9 Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global PCSK9 Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global PCSK9 Inhibitors Revenue Share by Type (2017-2022)
Table 34. Global PCSK9 Inhibitors Revenue Share by Type (2023-2028)
Table 35. PCSK9 Inhibitors Price by Type (2017-2022) & (USD/Unit)
Table 36. Global PCSK9 Inhibitors Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 38. Global PCSK9 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 39. Global PCSK9 Inhibitors Sales Share by Application (2017-2022)
Table 40. Global PCSK9 Inhibitors Sales Share by Application (2023-2028)
Table 41. Global PCSK9 Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global PCSK9 Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global PCSK9 Inhibitors Revenue Share by Application (2017-2022)
Table 44. Global PCSK9 Inhibitors Revenue Share by Application (2023-2028)
Table 45. PCSK9 Inhibitors Price by Application (2017-2022) & (USD/Unit)
Table 46. Global PCSK9 Inhibitors Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 48. North America PCSK9 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 49. North America PCSK9 Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America PCSK9 Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 52. North America PCSK9 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 53. North America PCSK9 Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America PCSK9 Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 56. North America PCSK9 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 57. North America PCSK9 Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America PCSK9 Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 60. Europe PCSK9 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 61. Europe PCSK9 Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe PCSK9 Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 64. Europe PCSK9 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 65. Europe PCSK9 Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe PCSK9 Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 68. Europe PCSK9 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 69. Europe PCSK9 Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe PCSK9 Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific PCSK9 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific PCSK9 Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific PCSK9 Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific PCSK9 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific PCSK9 Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific PCSK9 Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific PCSK9 Inhibitors Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific PCSK9 Inhibitors Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific PCSK9 Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific PCSK9 Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 84. Latin America PCSK9 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 85. Latin America PCSK9 Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America PCSK9 Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 88. Latin America PCSK9 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 89. Latin America PCSK9 Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America PCSK9 Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 92. Latin America PCSK9 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 93. Latin America PCSK9 Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America PCSK9 Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa PCSK9 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa PCSK9 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa PCSK9 Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa PCSK9 Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa PCSK9 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa PCSK9 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa PCSK9 Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa PCSK9 Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa PCSK9 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa PCSK9 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa PCSK9 Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa PCSK9 Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 107. Amgen Corporation Information
Table 108. Amgen Description and Major Businesses
Table 109. Amgen PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Amgen PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Amgen Recent Developments
Table 112. Eli Lilly Corporation Information
Table 113. Eli Lilly Description and Major Businesses
Table 114. Eli Lilly PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Eli Lilly PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Eli Lilly Recent Developments
Table 117. Sanofi Corporation Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Sanofi PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Pfizer Corporation Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Pfizer PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Novartis Corporation Information
Table 128. Novartis Description and Major Businesses
Table 129. Novartis PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Novartis PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novartis Recent Developments
Table 132. Roche Corporation Information
Table 133. Roche Description and Major Businesses
Table 134. Roche PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Roche PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Roche Recent Developments
Table 137. Merck Corporation Information
Table 138. Merck Description and Major Businesses
Table 139. Merck PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Merck PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck Recent Developments
Table 142. Alnylam Corporation Information
Table 143. Alnylam Description and Major Businesses
Table 144. Alnylam PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Alnylam PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Alnylam Recent Developments
Table 147. AstraZeneca Corporation Information
Table 148. AstraZeneca Description and Major Businesses
Table 149. AstraZeneca PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. AstraZeneca PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. AstraZeneca Recent Developments
Table 152. Affiris Corporation Information
Table 153. Affiris Description and Major Businesses
Table 154. Affiris PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Affiris PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Affiris Recent Developments
Table 157. BMS Corporation Information
Table 158. BMS Description and Major Businesses
Table 159. BMS PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. BMS PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. BMS Recent Developments
Table 162. Ionis Pharmaceuticals Corporation Information
Table 163. Ionis Pharmaceuticals Description and Major Businesses
Table 164. Ionis Pharmaceuticals PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Ionis Pharmaceuticals PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Ionis Pharmaceuticals Recent Developments
Table 167. Cyon Therapeutics Corporation Information
Table 168. Cyon Therapeutics Description and Major Businesses
Table 169. Cyon Therapeutics PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Cyon Therapeutics PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Cyon Therapeutics Recent Developments
Table 172. Daiichi Sankyo Corporation Information
Table 173. Daiichi Sankyo Description and Major Businesses
Table 174. Daiichi Sankyo PCSK9 Inhibitors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Daiichi Sankyo PCSK9 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Daiichi Sankyo Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. PCSK9 Inhibitors Distributors List
Table 180. PCSK9 Inhibitors Customers List
Table 181. PCSK9 Inhibitors Market Trends
Table 182. PCSK9 Inhibitors Market Drivers
Table 183. PCSK9 Inhibitors Market Challenges
Table 184. PCSK9 Inhibitors Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. PCSK9 Inhibitors Product Picture
Figure 3. Global PCSK9 Inhibitors Market Share by Type in 2021 & 2028
Figure 3. Epatha(Evolocumab) Product Picture
Figure 4. Praluent(Alirocumab) Product Picture
Figure 5. Bococizumab Product Picture
Figure 6. Others Product Picture
Figure 7. Global PCSK9 Inhibitors Market Share by Application in 2021 & 2028
Figure 8. Clinical Application
Figure 9. Drug Development
Figure 10. Other
Figure 11. PCSK9 Inhibitors Report Years Considered
Figure 12. Global PCSK9 Inhibitors Sales 2017-2028 (K Units)
Figure 13. Global PCSK9 Inhibitors Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global PCSK9 Inhibitors Revenue 2017-2028 (US$ Million)
Figure 15. Global PCSK9 Inhibitors Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global PCSK9 Inhibitors Sales Market Share by Region (2017-2022)
Figure 17. Global PCSK9 Inhibitors Sales Market Share by Region (2023-2028)
Figure 18. North America PCSK9 Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 19. North America PCSK9 Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe PCSK9 Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 21. Europe PCSK9 Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific PCSK9 Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific PCSK9 Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America PCSK9 Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America PCSK9 Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa PCSK9 Inhibitors Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa PCSK9 Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The PCSK9 Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of PCSK9 Inhibitors in the World: Market Share by PCSK9 Inhibitors Revenue in 2021
Figure 30. Global PCSK9 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
Figure 32. Global PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 33. Global PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
Figure 34. Global PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 35. North America PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
Figure 36. North America PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 37. North America PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
Figure 38. North America PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 39. North America PCSK9 Inhibitors Sales Share by Country (2017-2028)
Figure 40. North America PCSK9 Inhibitors Revenue Share by Country (2017-2028)
Figure 41. U.S. PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 42. Canada PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 43. Europe PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
Figure 44. Europe PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 45. Europe PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
Figure 46. Europe PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 47. Europe PCSK9 Inhibitors Sales Share by Country (2017-2028)
Figure 48. Europe PCSK9 Inhibitors Revenue Share by Country (2017-2028)
Figure 49. Germany PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 50. France PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 52. Italy PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 53. Russia PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific PCSK9 Inhibitors Sales Share by Region (2017-2028)
Figure 59. Asia Pacific PCSK9 Inhibitors Revenue Share by Region (2017-2028)
Figure 60. China PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 61. Japan PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 63. India PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 64. Australia PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
Figure 71. Latin America PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 72. Latin America PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
Figure 73. Latin America PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 74. Latin America PCSK9 Inhibitors Sales Share by Country (2017-2028)
Figure 75. Latin America PCSK9 Inhibitors Revenue Share by Country (2017-2028)
Figure 76. Mexico PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa PCSK9 Inhibitors Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa PCSK9 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa PCSK9 Inhibitors Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa PCSK9 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa PCSK9 Inhibitors Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa PCSK9 Inhibitors Revenue Share by Country (2017-2028)
Figure 85. Turkey PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E PCSK9 Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 88. PCSK9 Inhibitors Value Chain
Figure 89. PCSK9 Inhibitors Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Industry Market Size
